Three-dimensional conformal external beam radiotherapy (3D-CRT) for accelerated partial breast irradiation (APBI): What is the correct prescription dose?

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 29, Issue 5, 2006, Pages 474-478

  Cuttino, Laurie W ^a   Todor, Dorin ^a   Pacyna, Lynn ^a   Lin, Peck Sun ^a   Arthur, Douglas W ^a,b  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Accelerated partial breast irradiation; Brachytherapy; Breast cancer; Breast conserving therapy; Dose

Indexed keywords

ACCELERATED PARTIAL BREAST IRRADIATION; ARTICLE; BRACHYTHERAPY; BREAST CANCER; BREAST SPARING THERAPY; CANCER THERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; COMPUTER PROGRAM; EQUIVALENT UNIFORM BIOLOGICALLY EFFECTIVE DOSE; EXTERNAL BEAM RADIOTHERAPY; HUMAN; INTERSTITIAL RADIATION; MAXIMUM EQUIVALENT FRACTION SIZE; MEAN EQUIVALENT FRACTION SIZE; PRESCRIPTION; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION DOSE FRACTIONATION; RADIOBIOLOGY; THREE DIMENSIONAL CONFORMAL EXTERNAL BEAM RADIOTHERAPY; TREATMENT PLANNING;

BRACHYTHERAPY; BREAST NEOPLASMS; DOSE FRACTIONATION; HUMANS; RADIOTHERAPY, CONFORMAL;

EID: 33749543693     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/01.coc.0000225409.99284.f2     Document Type: Article

References (29)

1. Arthur DW, Vicini FA. Accelerated partial breast irradiation as a part of breast conservation therapy. J Clin Oncol. 2005;23:1726-1735.
2. Wazer D, Berle L, Graham R, et al. Preliminary results of a phase I/II study of HDR brachytherapy alone for T1/T2 breast cancer. Int J Radiat Oncol Biol Phys. 2002;53:889-897.
3. Vicini F, Kestin L, Chen P, et al. Limited-field radiation therapy in the management of early-stage breast cancer. J Natl Cancer Inst. 2003;95:1205-1210.
4. King T, Bolton J, Kuske R, et al. Long-term results of wide-field brachytherapy as the sole method of radiation therapy after segmental mastectomy for T(is,1,2) breast cancer. Am J Surg. 2000;180:299-304.
5. Arthur D, Koo D, Zwicker R. Partial breast brachytherapy following lumpectomy: a low dose rate and high dose rate experience. Int J Radiat Oncol Biol Phys. 2003;56:681-689.
6. Kuske R, Winter K, Arthur D, et al. A phase II trial of brachytherapy alone following lumpectomy for stage I or II breast cancer: initial outcomes of RTOG 95-17 (Abstract 565). Proc American Soc Clin Oncol. 2004;23:18.
7. Krishnan L, Jewell W, Tawfik O, et al. Breast conservation therapy with tumor bed irradiation alone in a selected group of patients with stage I breast cancer. Breast J. 2001;7:91-96.
8. Cionini L, Pacini P, Marzano S. Exclusive brachytherapy after conservative surgery in cancer of the breast. Lyon Chir. 1993;89:128.
9. Lawenda B, Taghian A, Kachnic L, et al. Dose-volume analysis of radiotherapy for T1N0 invasive breast cancer treated by local excision and partial breast irradiation by low-dose-rate interstitial implant. Int J Radiat Oncol Biol Phys. 2003;56:671-680.
10. Das R, Patel R, Shah H, et al. 3D CT-based high-dose rate breast brachytherapy implants: treatment planning and quality assurance. Int J Radiat Oncol Biol Phys. 2004;59:1224-1228.
11. Polgar C, Sulyok Z, Fodor J, et al. Sole brachytherapy of the tumor bed after conservative surgery for T1 breast cancer: five-year results of a phase I/II study and initial findings of a randomized phase III trial. J Surg Oncol. 2002;80:121-128.
12. Polgar C, Major T, Fodor J, et al. High-dose rate bracytherapy alone versus whole breast radiotherapy with or without tumor bed boost after breast conserving surgery: seven year results of a comparative study. Int J Radiat Oncol Biol Phys. 2004;60:1171-1181.
13. Vicini F, Arthur D, Polgar C, et al. Defining the efficacy of accelerated partial breast irradiation: the importance of proper patient selection, quality assurance, and common sense. Int J Radiat Oncol Biol Phys. 2003;57:1210-1213.
14. Baglan K, Sharpe M, Jaffray D, et al. Accelerated partial breast irradiation using 3D conformal radiation therapy (3D-CRT). Int J Radiat Oncol Biol Phys. 2003;55:302-311.
15. Vicini F, Remouchamps V, Wallace M, et al. Ongoing clinical experience using 3D conformal external beam radiotherapy to deliver partialbreast irradiation in patients with early stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys. 2003;57:1247-1253.
16. Formenti S, Rosenstein B, Skinner K, et al. T1 stage breast cancer: adjuvant hypo-fractionated conformal radiation therapy to tumor bed in selected post-menopausal breast cancer patients-pilot feasibility study. Radiology. 2002;222:171-178.
17. Formenti S, Troung M, Goldberg J, et al. Prone accelerated partial breast irradiation after breast-conserving surgery: preliminary clinical results and dose-volume histogram analysis. Int J Radiat Oncol Biol Phys. 2004;60:494-504.
18. Vicini F, Pass H, Wong J, et al. A Phase I/II Trial to Evaluate Three Dimensional Conformal Radiation Therapy (3D-CRT) Confined to the Region of the Lumpectomy Cavity for Stage I and II Breast Carcinoma. Philadelphia, PA: Radiation Therapy Oncology Group, protocol; 2003; #0319
19. Rosenstein B, Lymberis S, Formenti S. Biologic comparison of partial breast irradiation protocols. Int J Radiat Oncol Biol Phys. 2004;60:1393-1404.
20. Niemierko A. Reporting and analyzing dose distributions: a concept of equivalent uniform dose. Med Phys. 1997;24:103-110.
21. Jones L, Hoban P. Treatment plan comparison using equivalent uniform biologically effective dose (EUBED). Phys Med Biol. 2000;45:159-170.
22. Fowler JF. The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol. 1989;62:679-694.
23. Thames H, Bentzen S, Turesson I, et al. Time-dose factors in radiotherapy: a review of the human data. Radiother Oncol. 1990;19:219-235.
24. Steel G, Deacon J, Duchesne G, et al. The dose-rate effect in human tumour cells. Radiother Oncol. 1987;9:299-310.
25. Matthews J, Meeker B, Chapman J, et al. Response of human tumor cell lines in vitro to fractionated irradiation. Int J Radiat Oncol Biol Phys. 1989;16:133-138.
26. Yamada Y, Ackerman I, Franssen E, et al. Does the dose fractionation schedule influence local control of adjuvant radiotherapy for early stage breast cancer? Int J Radiat Oncol Biol Phys. 1999;44:99-104.
27. Williams M, Denekamp J, Fowler J. A review of alpha/beta ratios for experimental tumors: implications for clinical studies of altered fractionation. Int J Radiat Oncol Biol Phys. 1985;11:87-96.
28. Guerrero M, Li X. Analysis of a large number of clinical studies for breast cancer radiotherapy: estimation of radiobiological parameters for treatment planning. Phys Med Biol. 2003;48:3307-3326.
29. Vicini F, White J, Arthur D, et al. NSABP Protocol B39/RTOG 0413. A randomized phase III study of conventional whole breast irradiation versus partial breast irradiation for women with stage 0, I, or II breast cancer. www.rtog.org. 2004.